Medi-Cal Cuts Coverage for GLP‑1 Medications in California
California’s Medi-Cal program has announced a major policy change that will affect millions of Medi-Cal beneficiaries. Starting January 1, 2026, Medi-Cal will no longer cover GLP‑1 medications such as Ozempic and Wegovy when prescribed solely for weight loss. These medications, originally developed to treat type 2 diabetes, have become increasingly popular for weight management. However, […]
Medi-Cal Cuts Coverage for GLP‑1 Medications in California Read More »